|
|
42
|
|
|
B4616
|
|
|
DAPAGLIFLOZIN|METFORMIN 5MG|1G TAB (ZHL)
|
|
|
DAPAGLIFLOZIN|METFORMIN
|
|
|
DAPAGLIFLOZIN|METFORMIN
|
|
|
3X10
|
|
|
A
|
|
|
6.33
|
|
|
0.21
|
|
|
5MG|1G
|
|
|
TAB
|
|
|
30
|
|
|
BLIS
|
|
|
ZHL
|
|
|
ZENITH HEALTHCARE LIMITED
|
|
|
SBI
|
|
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
|
B
|
|
|
Anti-Diabetic
|
|
|
2026-04-01
|
|
|
2028-03-31
|
|
|
No
|
|
|
No
|
|
|
|
|
|
0
|
|
|
N
|
|
|
682018
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
|
|
|
ORAL
|
|
|
6
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
|